Market Overview:
The global medical beauty injections market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for minimally invasive procedures and rising awareness about medical aesthetics. In terms of type, filler materials are expected to account for the largest share of the market in 2018. This can be attributed to their ability to improve facial contours and reduce wrinkles. Supplementary materials are also expected to witness significant growth during the forecast period, owing to their ability restore volume and youthful appearance. By application, medical beauty institutions are expected account for the largest share of the market in 2018.
Product Definition:
Medical beauty injections are treatments that use a needle to inject a substance into the skin in order to improve its appearance. These substances can include Botox, collagen, and hyaluronic acid. Medical beauty injections are used to reduce the appearance of wrinkles, lines, and scars; plump up lips; and add volume to the face. They can also be used to improve skin tone and texture.
Filler Materials:
Filler materials are additives that are used to increase the volume of injectable formulations. They can be synthetic or natural and serve varied functions such as increasing stability, providing viscosity, improving flowability and reducing irritation & allergies.
Supplementary Materials:
supplementary materials are the substances that are added to a medical beauty injection for improving its effect. The most common types of supplementary materials include vitamins, minerals, and botanicals. These materials have no direct therapeutic value but they contribute indirectly to the healing process by enhancing the overall appearance and health of patients suffering from chronic diseases such as arthritis or cancer.
Application Insights:
The medical beauty injections market is segmented by application into medical beauty institutes, public hospitals, and non-public medical institutions. The non-public medical institution held the largest share of over 60% in 2017. This is due to the growing preference for aesthetic procedures among individuals aged 40 years and above as well as among obese patients seeking cosmetic surgeries. In addition, a rise in demand for minimally invasive treatments that reduce recovery time is expected to drive growth during the forecast period.
Medical beauties are gaining popularity across all age groups owing to their increasing awareness about health & hygiene issues coupled with rising disposable income levels in emerging economies such as India & China.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D activities, presence of key players, and high adoption rate for cosmetic procedures in this region as compared to other regions.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as growing medical tourism industry and rising disposable income of consumers coupled with demand for aesthetic surgeries from countries like China, India, Thailand among others are expected drive regional market growth during the estimated time span. In addition, availability of skilled professionals at a low cost will further boost regional demand during 2018-2030 time frame.
Growth Factors:
- Increasing demand for minimally invasive procedures: The global medical beauty injections market is witnessing a shift towards minimally invasive procedures, which offer several benefits over traditional surgical procedures. This is primarily attributed to the growing awareness about the advantages of these procedures among patients and healthcare professionals.
- Rising prevalence of skin disorders: The increasing prevalence of skin disorders such as acne, wrinkles, and pigmentation is driving the demand for medical beauty injections products and services worldwide. According to a study by MarketsandMarkets, the global acne therapeutics market is expected to reach USD 7.8 billion by 2020.
- Growing popularity of non-invasive treatments: A large number of people are now preferring non-invasive treatments such as medical beauty injections over traditional surgical procedures due to their safety and efficacy profiles. This is likely to boost the growth prospects of the global medical beauty injections market in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Beauty Injections Market Research Report
By Type
Filler Materials, Supplementary Materials, Support Materials, Shrinking Materials
By Application
Medical Beauty Institution, Public Hospital, Non-public Medical Institution
By Companies
AbbVie, LG Chem, Haohai Biological Technology, Bloomage Biotechnology, Galderma, Aimei Ke, Changchun Botai Pharmaceutical Biotechnology, Sunmax Biotechnology, Sinclair Pharma, Hafod BioScience B.V.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
200
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Medical Beauty Injections Market Report Segments:
The global Medical Beauty Injections market is segmented on the basis of:
Types
Filler Materials, Supplementary Materials, Support Materials, Shrinking Materials
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical Beauty Institution, Public Hospital, Non-public Medical Institution
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AbbVie
- LG Chem
- Haohai Biological Technology
- Bloomage Biotechnology
- Galderma
- Aimei Ke
- Changchun Botai Pharmaceutical Biotechnology
- Sunmax Biotechnology
- Sinclair Pharma
- Hafod BioScience B.V.
Highlights of The Medical Beauty Injections Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Filler Materials
- Supplementary Materials
- Support Materials
- Shrinking Materials
- By Application:
- Medical Beauty Institution
- Public Hospital
- Non-public Medical Institution
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Beauty Injections Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical beauty injections are a type of cosmetic treatment that use medications to improve the appearance of skin, hair, and nails. These treatments can be used to treat a variety of conditions, such as wrinkles, age spots, and thinning hair.
Some of the key players operating in the medical beauty injections market are AbbVie, LG Chem, Haohai Biological Technology, Bloomage Biotechnology, Galderma, Aimei Ke, Changchun Botai Pharmaceutical Biotechnology, Sunmax Biotechnology, Sinclair Pharma, Hafod BioScience B.V..
The medical beauty injections market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical Beauty Injections Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Medical Beauty Injections Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Medical Beauty Injections Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Medical Beauty Injections Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Medical Beauty Injections Market Size & Forecast, 2018-2028
4.5.1 Medical Beauty Injections Market Size and Y-o-Y Growth
4.5.2 Medical Beauty Injections Market Absolute $ Opportunity
Chapter 5 Global Medical Beauty Injections Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Medical Beauty Injections Market Size Forecast by Type
5.2.1 Filler Materials
5.2.2 Supplementary Materials
5.2.3 Support Materials
5.2.4 Shrinking Materials
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Medical Beauty Injections Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Medical Beauty Injections Market Size Forecast by Applications
6.2.1 Medical Beauty Institution
6.2.2 Public Hospital
6.2.3 Non-public Medical Institution
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Medical Beauty Injections Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Medical Beauty Injections Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Medical Beauty Injections Analysis and Forecast
9.1 Introduction
9.2 North America Medical Beauty Injections Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Medical Beauty Injections Market Size Forecast by Type
9.6.1 Filler Materials
9.6.2 Supplementary Materials
9.6.3 Support Materials
9.6.4 Shrinking Materials
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Medical Beauty Injections Market Size Forecast by Applications
9.10.1 Medical Beauty Institution
9.10.2 Public Hospital
9.10.3 Non-public Medical Institution
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Medical Beauty Injections Analysis and Forecast
10.1 Introduction
10.2 Europe Medical Beauty Injections Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Medical Beauty Injections Market Size Forecast by Type
10.6.1 Filler Materials
10.6.2 Supplementary Materials
10.6.3 Support Materials
10.6.4 Shrinking Materials
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Medical Beauty Injections Market Size Forecast by Applications
10.10.1 Medical Beauty Institution
10.10.2 Public Hospital
10.10.3 Non-public Medical Institution
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Medical Beauty Injections Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Medical Beauty Injections Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Medical Beauty Injections Market Size Forecast by Type
11.6.1 Filler Materials
11.6.2 Supplementary Materials
11.6.3 Support Materials
11.6.4 Shrinking Materials
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Medical Beauty Injections Market Size Forecast by Applications
11.10.1 Medical Beauty Institution
11.10.2 Public Hospital
11.10.3 Non-public Medical Institution
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Medical Beauty Injections Analysis and Forecast
12.1 Introduction
12.2 Latin America Medical Beauty Injections Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Medical Beauty Injections Market Size Forecast by Type
12.6.1 Filler Materials
12.6.2 Supplementary Materials
12.6.3 Support Materials
12.6.4 Shrinking Materials
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Medical Beauty Injections Market Size Forecast by Applications
12.10.1 Medical Beauty Institution
12.10.2 Public Hospital
12.10.3 Non-public Medical Institution
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Medical Beauty Injections Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Medical Beauty Injections Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Medical Beauty Injections Market Size Forecast by Type
13.6.1 Filler Materials
13.6.2 Supplementary Materials
13.6.3 Support Materials
13.6.4 Shrinking Materials
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Medical Beauty Injections Market Size Forecast by Applications
13.10.1 Medical Beauty Institution
13.10.2 Public Hospital
13.10.3 Non-public Medical Institution
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Medical Beauty Injections Market: Competitive Dashboard
14.2 Global Medical Beauty Injections Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AbbVie
14.3.2 LG Chem
14.3.3 Haohai Biological Technology
14.3.4 Bloomage Biotechnology
14.3.5 Galderma
14.3.6 Aimei Ke
14.3.7 Changchun Botai Pharmaceutical Biotechnology
14.3.8 Sunmax Biotechnology
14.3.9 Sinclair Pharma
14.3.10 Hafod BioScience B.V.
